| US 7,527,792 B1 | ||
| Pharmaceutical composition comprising an anti-cancer and at least a peptide | ||
| Jamal Temsamani, Nîmes (France); and Michel Kaczorek, Montferrier sur Lez (France) | ||
| Assigned to Synt : EM, Nimes (France) | ||
| Appl. No. 9/856,940 PCT Filed Nov. 26, 1999, PCT No. PCT/FR99/02939 § 371(c)(1), (2), (4) Date Dec. 06, 2001, PCT Pub. No. WO00/32237, PCT Pub. Date Jun. 08, 2000. |
||
| Claims priority of application No. 98/15073 (FR), filed on Nov. 30, 1998. | ||
| Int. Cl. A61K 39/38 (2006.01) | ||
| U.S. Cl. 424—184.1 | 1 Claim |
| 1. A pharmaceutical composition comprising at least one anti-cancer agent bonded to a peptide, said peptide consisting of the amino acid sequence of SEQ ID NO:14, and a pharmaceutically acceptable carrier. |